|
Age (years)
|
48 ±15
|
|
BMI
|
26 ±3.7
|
|
Female (%)
|
48
|
|
Male (%)
|
52
|
|
Diabetes (%)
|
14
|
|
Hypertension (%)
|
12
|
|
Other co-morbidities*(%)
|
11
|
|
HCV RNA quantitative*
|
2066.45±4000
|
|
ALT (IU/L)
|
53.5±40
|
|
AST (IU/L)
|
48±29
|
|
AFP (IU/L)
|
4.3±3.4
|
|
Albumin (g/dL)
|
4.1±0.5
|
|
Total bilirubin (mg/dL)
|
0.75±0.4
|
|
Indirect bilirubin (mg/dL)
|
0.48±0.4
|
|
WBCx103/mm3
|
7.1±2.2
|
|
Hb (g/dL)
|
13.5±1.8
|
|
Creatinine (mg/dL)
|
0.9±0.2
|
|
INR
|
1.1±0.1
|
|
Platelets×103/mm3
|
231.7±72
|
|
Fibrosis stage (F) by TE (%)
|
F0 (23%)
|
|
F1 (26%)
|
|
F2 (14 %)
|
|
F3 (9%)
|
|
F4 (28%)
|
- *Ischemic heart diseases and bronchial asthma
